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IMPLEMENTATION SCIENCE
Exploring the Experiences of Women and Health Care
Workers in the Context of PMTCT Option B Plus in Malawi
Fabian Cataldo, PhD,* Levison Chiwaula, PhD,*† Misheck Nkhata, MA,* Monique van Lettow, PhD,*
Florence Kasende, BA,* Nora E. Rosenberg, PhD,‡ Hannock Tweya, PhD,§ Veena Sampathkumar, MA,k
Mina Hosseinipour, PhD,‡ Erik Schouten, PhD,¶ Atupele Kapito-Tembo, PhD,# Michael Eliya, MD,**
Frank Chimbwandira, MD,** and Sam Phiri, PhD,§ for the PURE Malawi Consortium
Introduction: Malawi has embarked on a “test-and-treat”
approach to prevent mother-to-child transmission (PMTCT) of
HIV, known as “Option B+,” offering all HIV-infected pregnant
and breastfeeding women lifelong antiretroviral therapy (ART)
regardless of CD4 count or clinical stage. A cross-sectional
qualitative study was conducted to explore early experiences
surrounding “Option B+” for patients and health care workers
(HCWs) in Malawi.
Methods: Study participants were purposively selected across 6
health facilities in 3 regional health zones in Malawi. Semi-structured
interviews were conducted with women enrolled in “Option B+” (n =
24), and focus group discussions were conducted with HCWs
providing Option B+ services (n = 6 groups of 8 HCWs). Data were
analyzed using a qualitative thematic coding framework.
Results: Patients and HCWs identiﬁed the lack of male involve-
ment as a barrier to retention in care and expressed concerns at the
rapidity of the test-and-treat process, which makes it difﬁcult for
patients to “digest” a positive diagnosis before starting ART. Fear
regarding the breach of privacy and conﬁdentiality were also
identiﬁed as contributing to loss to follow-up of women initiated
under the Option B+. Disclosure remains a difﬁcult process within
families and couples. Lifelong ART was also perceived as an
opportunity to plan future pregnancies.
Conclusions: As “Option B+” continues to be rolled out, novel
interventions to support and retain women into care must be
implemented. These include providing space, time, and support to
accept a diagnosis before starting ART, engaging partners and
families, and addressing the need for peer support and conﬁdentiality.
Key Words: HIV, PMTCT, ART, test-and-treat, retention, uptake,
loss to follow-up, Option B+, Malawi
(J Acquir Immune Deﬁc Syndr 2017;74:517–522)
INTRODUCTION
In Malawi, a country of 15.9 million people in Southern
Africa, an estimated 10.3% (9.6%–10.8%) of adults are HIV
positive, and an estimated 170,000 children younger than 15
years are living with HIV, most of whom were infected
through vertical transmission.1 Since July 2011, the Malawi
Ministry of Health has embarked on a program to prevent
mother-to-child transmission (PMTCT) of HIV known as
“Option B Plus” (Option B+). Malawi became the ﬁrst
country to implement a test-and-treat approach in a national
PMTCT program: Option B+ offers all HIV-infected pregnant
and breastfeeding women lifelong antiretroviral therapy
(ART), regardless of CD4 count or clinical stage.2,3 The
overall goal of the program was to improve ART uptake and
retention, and thus the outcomes of HIV-infected pregnant
women, their uninfected partners, and their infants within the
continuum of HIV testing and treatment services.
The Option B+ strategy offers an attractive rapid ART
scale-up and was adopted in Malawi ahead of the recom-
mendations from the World Health Organization.4 Although
it has the potential to profoundly impact maternal and infant
outcomes, operational challenges throughout the cascade of
PMTCT services may affect uptake and adherence to ART by
pregnant women, the follow-up of HIV-exposed infants, and
the long-term retention of this population. From the onset,
potential threats to the implementation and scale-up of Option
B+ were identiﬁed and concerns were raised in relation to
initiation into care, retention in care, adherence to ART, and
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the lack of psycho-social support in the context of lifelong
retention of a relatively asymptomatic population group.3
During its ﬁrst year of implementation in Malawi,
Option B+ rapidly expanded uptake and access to PMTCT
services, with a 7-fold increase in the number of women
starting ART for PMTCT.5,6 One of the main challenges
encountered to date is the retention of women once initiated
on ART. In the ﬁrst year of implementation, a large pro-
portion of women (17%) seemed to be “lost to follow-up”
(LTFU) 6 months after ART initiation, with most losses
occurring in the ﬁrst 3 months of therapy.7 Many women
recorded as initiated on treatment and who accepted their ﬁrst
month of ART never come back, raising additional questions
on whether they initiated treatment. Early assessments into
the reasons associated with stopping ART among women
who initiated treatment during Option B+ pointed at difﬁcul-
ties linked to traveling to health facilities and lack of transport
money, not understanding initial treatment guidance, and
being too weak, sick, or experiencing treatment side effects.8
In light of these potential challenges to the implemen-
tation of Option B+ in Malawi, a cluster randomized control
trial, PURE (PMTCT Uptake and Retention in Malawi), was
designed to evaluate and compare strategies to strengthen
uptake and retention of mothers and families in PMTCT care.
The trial compares facility-based peer support and
community-based peer support to standard of care across
the South East, South West, and Central West regions.9
Interventions include the introduction of trained expert
patients (Mentor Mothers and Expert Mothers), who are
working within and outside health facilities to support women
involved in Option B+ and their families. In this article, we
describe the results from a qualitative formative study
designed to reﬁne the PURE trial intervention arms. The
aim of this study was to explore the experience of patients and
health care workers (HCWs) in relation to the implementation
of Option B+. The speciﬁc objectives were to elicit local
perceptions of Option B+ among HCWs and women who
have recently been enrolled in this program and to document
the nature of the support provided to these women.
METHODS
Study Design
This was descriptive, cross-sectional formative
research, drawing on a qualitative approach to collect data
through semi-structured interviews and focus group discus-
sions with both Option B+ patients and HCWs.
Study Sites
The study was conducted in 6 of 21 facilities within the
PURE trial sites across 3 health zones (Central West, South
East, and South West).9 Among the 21 study sites included in
the PURE trial, 2 sites were purposively selected for this
analysis in each health zone. In addition, in each health zone,
we selected 2 sites that were different according to their
location (rural vs urban settings), number of pregnant and/or
breastfeeding women attending services in the past quarter
(large vs smaller facilities), and type of ownership of the
health facility (Ministry of Health vs Christian Health
Association Malawi). The health facilities identiﬁed as study
sites for the study are shown in Figure 1.
Participant Selection
Study participants were recruited through a purposive
sampling approach at each study site until the sample of
respondents was achieved. In each site, the research team
identiﬁed 4 women newly initiating ART services and
enrolled in Option B+, and all available HCWs involved in
providing services as part of Option B+. Our intention was to
interview a small sample of individuals until thematic
saturation is achieved. Based on previous studies conducted
in the same setting in relation to PMTCT services, we
expected that saturation would be achieved at 20–30 inter-
views; we therefore selected 24 interviews (4 per site) as
a suitable number of women to be interviewed.
HCWs recruited for the study included nurses, medical
assistants, and community health workers (Health Surveil-
lance Assistants) who routinely provided PMTCT care in the
selected health facilities. Patients involved in the study
included HIV-infected pregnant or breastfeeding women
seeking antenatal care (ANC) or initiating ART services at
1 of the 6 study sites. In total, 48 HCWs and 24 women
receiving care as part of Option B+ were included in
this study.
Data Collection
All data were collected at the health facilities at a time
identiﬁed as convenient by research participants themselves.
Data collection methods included semi-structured interviews
and focus group discussions. Semi-structured interviews were
conducted with 4 patients in each study site (n = 24). One
focus group discussion was conducted with 8 HCWs per
facility (n = 6 groups of 8 individuals). Data collection took
FIGURE 1. Geographic distribution of the 6 PURE formative
sites in the South East, South West, and Central West zones of
the country (Mulanje District Hospital and Muloza Health
Centre in the South East zone; Trinity Mission Hospital and
Makhetha Health Centre in the South West zone; and Nsipe
Health Centre and Lobi Rural Hospital in the Central East/
Central West zone).
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place from April to June 2013. (A follow-up longitudinal
study is collecting additional data alongside the PURE trial
implementation from 2014 to 2016). A team of 4 data
collectors was recruited and trained in recruitment of study
participants, data collection, and appropriate conduct during
ﬁeldwork, including ethical considerations. All data collectors
had previous experience in collecting qualitative data and
conducting interviews and received additional training spe-
ciﬁc to this study. Data were recorded on digital audio
recorder in the local language Chichewa.
Data Analysis
Recordings of interviews and focus group discussions
were transcribed in Chichewa and later translated verbatim to
English. The quality of the transcription was checked by
a bilingual researcher who used the original transcripts and
extracts from the audio ﬁles to check the ﬁnal translation. Data
were anonymized and pseudonyms were used to protect the
identity of research participants. Based on a sample of 10
transcripts from interviews and focus groups, the research team
identiﬁed themes primarily through a deductive approach.10,11
Using a framework analysis12 approach, themes were devel-
oped to capture common issues, such as perception and
acceptability of current care, adherence and loss to follow-
up, care relationships, disclosure, and task-shifting involving
community HCWs. A coding structure reﬂecting each of the
themes and subthemes was applied to the data using Nvivo 7.
Framework and thematic analysis of the retrieved data were
followed by a narrative account of the ﬁndings.
Ethical Considerations
Data were collected with respect for international
ethical guidelines, aiming at protecting conﬁdentiality and
anonymity, ensuring informed consent, giving ample time
and information about the study to respondents, and
interviewing study participants in location allowing for
audio privacy. All study participants provided written
informed consent. Study participants did not receive an
incentive to be part of the study but they received a transport
reimbursement (equivalent USD 1.40) for taking part in the
interviews and focus group discussions. The study protocol
was approved by the National Health Sciences Research
Committee in Malawi, the University of North Carolina
Institutional Review Board, The University of Toronto
Research Ethics Board, and the World Health Organization
Ethics Review Committee.
RESULTS
Women interviewed were between 19 and 40 years old
(mean age: 28 years). All but 2 were married (one was not
married and the other was divorced), and all but 3 had 1 child
(3 were pregnant). Most had reached junior primary school,
and 8 of 24 had completed the ﬁrst or second years of senior
primary school. For those who had an economic activity, this
ranged from farming (6 of 24), small business (7 of 24), and
small labor or seasonal work in tea plantations (4 of 24).
Results are presented across 3 main themes: the
perception of Option B+ by patients and HCWs; experiences
of adherence and loss to follow-up in the context of Option
B+; and patients’ and HCWs’ perspectives on improving
Option B+.
Perception of Option B+ by Patients
and HCWs
Several of the women interviewed were tested for HIV
during pregnancy and talked about how they accepted their
diagnoses and sought treatment. Some respondents also narrated
their desire to have more children in the future, which was
sometimes linked to the perspective of getting better on ART.
Distance, privacy, and conﬁdentiality remain problem-
atic issues for women, especially for those living in rural
areas; they expressed feeling stigmatized in relation to living
with HIV, within their social network and during their visits
to the health centers. In most cases, women were reluctant to
share their serostatus beyond a small circle of people because
they feared discrimination. Several of the women interviewed
had not disclosed their serostatus to more than one person:
No one knows because I have never explained
this to anyone as it is only me and my husband
that know about this. [Nsipe] I have just told my
husband, but I have not told my children since
they are with my mother. [Makhetha]
Across several health centers, women criticized the lack
of privacy in HIV and ART services, with conﬁdentiality
around their serostatus compromised each time they go to the
clinic:
If you meet a person who knows you and is
seeing you enter the room where we get ARVs
[antiretrovirals], they tend to tell people that so
and so are on ARVs. [Lobi]
In each health facility, the women interviewed ex-
pressed how much stigma is still part of their lives and that
they still face discrimination when they choose to disclose
their serostatus to others:
Disclosure of HIV in my community is difﬁcult
because when people know that you are HIV
positive, they start telling each other about your
status. So wherever you go, people talk about
you. As such, I am open only to my family and
close friends. [Trinity]
Some of their close family members avoided coming to
their houses and, in 2 cases, the husbands decided to leave
after their partner tested positive:
Since I was found HIV positive [.] my husband
ran away from me. I have to support the child
alone. [Nsipe]
The lack of inclusion of male partners, and their
reluctance to be tested for HIV, was cited as an ongoing
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problem by women; some feared for the stability of their
relationship if their partner did not test. Many of the mothers
who expressed being supported by their partner to get an HIV
test and start treatment also reported that male partners
refused to get tested or to start ART themselves:
My husband is refusing to go for testing,
therefore I don’t know if my family will continue
to live in this situation. [.] will the marriage
come to an end? [Muloza]. My husband supports
me but he doesn’t take the drugs. [Nsipe]
From the HCWs’ perspective, Option B+ was posi-
tively received as it encouraged deliveries at health facilities
to get babies on nevirapine within 72 hours. They also
expressed positive views about the intensiﬁed testing of
newborns and that Option B+ would encourage continuous
breastfeeding until 24 months.
Across all sites, HCWs complained about the lack of
infrastructure and the recurrent shortage of HIV test kits.
Some HCWs expressed challenges to identify the address and
exact name of patients for follow-up.
Importantly, HCWs reported that some mothers expe-
rience difﬁculties in understanding why they are initiated on
ART immediately after testing. HCWs were concerned that
the “test-and-treat” approach is “too fast” and too much
information is given to women at once, with no time to digest
and communicate a new positive HIV diagnosis:
We test her [a patient] today and she is found HIV
positive, we immediately initiate her onto ART
whilst she is still thinking about how she con-
tracted the virus and she hasn’t yet accepted the
reality about her serostatus, and we give her the
drugs for her unborn child at the same time. So it’s
like she is getting too much information at once
before she makes the rightful decision [Mulanje].
Another challenge experienced by HCWs is that,
because of staff shortages, some mothers are asked to come
back another day to be tested. Similarly to patients, HCWs
highlighted the lack of privacy and conﬁdentiality when
patients came for testing or to pick up ART:
The space where VCT [voluntary counseling
and testing] and ART clinics are conducted is
small, so on ART day the space
is overcrowded. Therefore privacy is
compromised. [Nsipe]
Adherence and Loss to Follow-up in Option B+
Most women interviewed self-reported that they were
adhering to treatment by taking ART as prescribed and
understood that they should take treatment for life:
They explained to me that I would be taking these
drugs daily for the rest of my life. [Nsipe]
Despite declaring that they adhered to treatment, and
generally understanding well how to take ART, nearly all
mothers and HCWs interviewed reported problems linked to
retention in care and adherence to ART; some patients
reported missing doses of ART while they continued to
collect treatment regularly from the clinic.
HCWs reported that several mothers did not come back
after delivery or after their ﬁrst visit to the health facility.
HCWs expressed that patients feel “discouraged” when they
see people they know queuing for ART. HCWs reported that
the LTFU may be explained by the fact that women are
expected to start treatment immediately, sometimes while
they are still in the labor ward:
Once we diagnose them [patients] positive, we
immediately initiate them on ART. So you ﬁnd
that most of them don’t come for subsequent
visits because they were introduced to ARVs
while in pain. This is a common problem and
most of the defaulters belong to this category of
ladies initiated at labour ward. [Trinity]
A key concern expressed by HCWs was that they do
not always know how to follow-up with the mothers who may
be defaulting. Some HCWs noted that the loss to follow-up
was also because of the lack of involvement of male partners
in PMTCT care, for instance, because men did not accom-
pany women to ANC or because they were not routinely
tested for HIV and followed-up within PMTCT services:
Because men don’t accompany their spouses to
antenatal clinic, it happens that once the lady
delivers and she is not suffering from any disease,
she does not see the reasons for coming to the
clinic to continue ART treatment. This is because
men are not involved. [Trinity]
Perspectives on Improving Option B+
When asked how one can improve the current PMTCT
care in Malawi, the main suggestion from women and HCWs
was to encourage more men to come forward for HIV testing
and to start treatment when required, for example, by
improving couple counseling and testing initiatives. Many
patients would have liked additional “life skills” advice (for
example, skills to be empowered to improve their day-to-day
situation) to be included in the care package that they received
at health facilities. Family planning and contraception as well
as nutrition and income-generating activities were cited as
important aspects of PMTCT services to be considered.
Another suggestion from patients to improve PMTCT care
was to address the issues around privacy and conﬁdentiality.
Some suggested having a speciﬁc day for ART visits to get
drugs “as a group”:
[In order to improve conﬁdentiality] we should
have a special day for ART visits to get drugs as
a group. [Nsipe]
From the HCWs’ perspective, more training was
necessary to help patients enrolled in Option B+. Distance,
especially among rural health facilities, was an obstacle to
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trace patients LTFU. HCWs suggested that task sharing with
Health Surveillance Assistants (HSAs) was important to link
patients back to care and that bikes and motorbikes could help
them to address this issue:
We have many clients who come from far and we
do not know if their reason for defaulting might
be that they are dead or not, so if we can have
another motorbike and make the effective follow-
ups we can have a successful ART. [Lobi]
DISCUSSION
This study explored the experiences of women and
HCWs in the context of the early rollout of Option B+ in
Malawi. Our ﬁndings illustrate that patients and HCWs
identiﬁed the lack of male involvement as a barrier to
retention in care and expressed concerns at the rapidity of
the test-and-treat process. Fear regarding the breach of
privacy and conﬁdentiality were also identiﬁed as contribut-
ing to loss to follow-up of women initiated under the Option
B+ strategy. Similar to recent studies exploring the challenges
to implementing Option B+ in Malawi, we note that stopping
treatment within the ﬁrst few months of ART initiation may
be linked to lack of means of travel and transport money, not
understanding how to take ART, informal transfers between
health facilities, or being too weak/sick and drugs side
effects.8
In addition to health systems barriers, such as the
irregular availability of CPT and HIV test kits, and the lack of
infrastructure and human resources for health, our ﬁndings
illustrate that stigma, conﬁdentiality, and privacy remain
central concerns for women accessing PMTCT services in
the context of Option B+. As described by others,13–16 despite
the broader availability of ART, women continue to fear
stigma in relation to being publicly identiﬁed as living
with HIV.
To understand the experience of receiving care and
support under Option B+, it is crucial to consider the different
cadres of HCWs involved in providing PMTCT care; HSAs,
in particular, have an important role to play, especially
outside health facilities. HSAs perform a number of tasks
within the PMTCT cascade, often without receiving addi-
tional specialized training, for example, to carry out tracing
activities. HSAs are required to spend a considerable portion
of their time in health facilities to assist HCWs; as their roles
and responsibilities continue to expand in the context of
Option B+, it is important for their roles to be rationalized to
ensure that they are not overwhelmed by the large number of
tasks that are shifted to them.
Some of the key reasons identiﬁed by HCWs as
contributing to early loss to follow-up include lack of support
from family members, fear for breach of conﬁdentiality,
feeling discouraged at the prospect of lifelong ART, and lack
of partner involvement. Male partner involvement is viewed
as a key intervention by patients and HCWs and remains
inadequately addressed in current PMTCT interventions.
However, as others17 have noted, male partner involvement
in PMTCT care is fragmented and, at best, associated with
ﬁrst ANC and couple HIV counseling and testing, suggesting
poor integration of male involvement into existing programs.
Similar to a study from Nigeria,18 our results indicate
that nondisclosure is a factor that may contribute to non-
retention in Option B+. Disclosure remains a limited and
difﬁcult process within families and more particularly within
couples. In addition, our data support the results described in
other studies that explored couple testing and disclosure13,19–24;
although male involvement is associated with better early
retention on ART, a majority of pregnant women living with
HIV face difﬁculties in sharing their serostatus with their
partners and fear being rejected by their partners.
Importantly, patients and HCWs were concerned about
the rapidity of the process for same day test-and-treat. Our
study highlights key concerns regarding the immediate nature
of this approach, where patients are given little time to “digest”
a new diagnosis and start treatment. This was highlighted by
patients and HCWs as a crucial concern regarding the
implementation of Option B+. Our results conﬁrm that some
women may ﬁnd PMTCT intervention coercive7,13 or that they
are not adequately prepared to start ART.7 In addition, in rural
Malawi, HIV testing may, in some cases, be incompatible with
marriage because it may be perceived as against ideals of trust,
love, and intimacy that couples strive for in their relation-
ships.25 Hence, the use of same-day HIV testing and ART
initiation may be contributing to the inadequate uptake of
treatment under Option B+, which points to the need to identify
alternatives or enhancements to this approach for women who
are unable to start treatment right away—for instance,
enhancing support for women after testing, tracing male
partners early, improve couple testing procedures, and help
women overcome the hurdle of disclosure.24,26
Limitations of the Study
Although study sites were carefully selected in relation to
criteria described in the methods section, the purposive
selection of patients and HCWs at each site may not reﬂect
some of the challenges of the current implementation of Option
B+. In addition, this study focused on patients currently
retained in care, who may have a different perspective on
Option B+ services to that of patients who have been LTFU.
CONCLUSIONS
As Option B+ continues to be rolled out across Malawi
and in several other sub-Saharan African countries, new
interventions to support women to be retained into care must
be implemented. Novel types of interventions, for instance,
providing care through other mothers who are also enrolled in
Option B+, are seen by some patients and HCWs as providing
more personal and family-centered peer-supported care, but
key questions remain as to how these interventions will cope
with patients’ perception of the quality of care received and
with expectations placed on peer support mothers. Current
Option B+ interventions should consider the lack of patient
agency during treatment initiation in relation to early loss to
follow-up; Interventions should improve processes to pro-
viding appropriate space, time, and support for patients to
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accept a positive HIV diagnosis before starting treatment,
engaging male partners and families into PMTCT care, and
addressing the need for peer support and conﬁdentiality
expressed by women who are already accessing PMTCT care.
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